W Communication Agency

Nordic launch of the K-haler


Mundipharma has a portfolio of medicines within diabetes, respiratory, oncology, pain and biosimilars. The k-haler is a breath-triggered inhaler, that automatically releases a dose of medication as the asthma patient breathes in through the mouthpiece. W was asked to support the launch of the k-haler in the Nordics by developing a communication platform campaign to communicate the key benefits of the k-haler to Healthcare Professionals (HCP).


Drawing from our in-depth knowledge within the asthma therapy area, the team at W developed a sales story flow and key selling messages to communicate the key benefits of the k-haler. A complex story with complex lung deposition data was translated to an understandable and compelling flow, targeting respiratory specialists treating asthma patients in a hospital setting.




After a process of content development and iteration, the k-haler sales presentation was developed as an iPad sales presentation with speaker notes. A tool enabling the Mundipharma sales team to have an interactive discussion with HCPs on the added value of k-haler compared to other breath-actuated inhalers for the management of asthma.


Would you like to learn more? Contact our Account Director Sunil Ramkali.

Related cases

More ON-time with APO-go “APO-go pen campaign”


Product launch- Alfa Laval “Premium goes prime”

Get news and inspiration from W straight to your inbox! Sign up for Whispers, our quarterly newsletter, right here:

product launches, brand development, digital strategies & tactics, life science,